Enabling earlier detection of infections
Early in its life as a company, Isomark LLC became certified through the WEDC’s Qualified New Business Venture Program, authorizing the company’s investors to receive up to $1 million in tax credits on the funds invested. Isomark also received a Technology Development Loan of $187,500 from WEDC to help finance the development and commercialization of its products and services. The loan and the investment Isomark was able to attract with the help of the tax credits have enabled the company to continue developing and testing its product, the Canary™ breath-based test that can detect infection within two hours of its onset.
Bringing a game-changing product to market
Isomark was founded in 2007 after a group of scientists from the University of Wisconsin-Madison discovered a way to use breath markers to detect infections earlier in patients—even before they experience symptoms—and that a market existed for the test in hospitals. In addition to WEDC resources, Isomark has received assistance from Merlin Mentors, UW-Madison’s Law and Entrepreneurship Clinic and the Center for Technology and Commercialization, as well as grants from the National Institutes of Health and UW-Madison and an investment from the Wisconsin Alumni Research Foundation.